Your session is about to expire
← Back to Search
Orthopedic Implant
Ankle Implant for Arthritis
N/A
Waitlist Available
Research Sponsored by Zimmer Biomet
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
The patient is > 18 years of age
The patient is skeletally mature
Must not have
The patient has ankle arthrodesis with malleolar exeresis, severe neurological or vascular disease, loss of musculature or neuromuscular compromise, severe instability, maltracking or misalignment of the tibia and talus uncorrectable by surgery compromising the affected limb
The patient has insufficient bone stock or bone quality to fix the components (i.e. osteoporosis, Charcot's disease)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights
No Placebo-Only Group
Summary
This trial studies a special ankle implant for patients needing ankle surgery. It aims to see how well the implant works in reducing pain and improving function. The implants have been developed to improve stability and longevity, with advancements in design and materials.
Who is the study for?
This trial is for adults over 18 with arthritis (degenerative, rheumatoid, or post-traumatic) who need ankle replacement surgery. They must be able to consent and follow the study's procedures. Excluded are prisoners, those mentally unable to participate, non-compliant individuals, pregnant women, patients with infections or poor bone quality, and those with severe limb issues.
What is being tested?
The Zimmer Trabecular Metal Total Ankle System is being tested in people needing ankle replacements due to arthritis. The study aims to track how well the implant works by looking at pain relief, improved function, life quality measures and checking x-rays for durability.
What are the potential side effects?
While not explicitly listed here, potential side effects may include pain at the implant site, swelling of the affected limb(s), infection risks around the new joint and possible allergic reactions if sensitive to materials used.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Select...
My bones have stopped growing.
Select...
I am eligible for an ankle replacement due to arthritis or injury.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have severe ankle issues or nerve/blood vessel diseases affecting my leg.
Select...
My bones are too weak or damaged to support surgical implants.
Select...
I have had an infection in my joint before.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Survivorship
Secondary study objectives
American Orthopaedic Foot and Ankle Society Score
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Zimmer TM Total Ankle SystemExperimental Treatment1 Intervention
Primary or revision total ankle arthroplasty subjects that receive the Zimmer Trabecular Metal Total Ankle System
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The Zimmer Trabecular Metal Total Ankle implant, like other joint replacement therapies, works by providing structural support and facilitating joint function. These implants replace damaged joint surfaces with metal and plastic components, which help to restore mobility and reduce pain.
The metal components offer durability and stability, while the plastic parts mimic the cushioning effect of cartilage. This is crucial for arthritis patients as it directly addresses joint degradation, alleviates pain, and improves overall joint function, thereby enhancing the patient's quality of life.
Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.Occupational therapy for rheumatoid arthritis.
Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.Occupational therapy for rheumatoid arthritis.
Find a Location
Who is running the clinical trial?
Zimmer BiometLead Sponsor
378 Previous Clinical Trials
67,975 Total Patients Enrolled
54 Trials studying Rheumatoid Arthritis
10,514 Patients Enrolled for Rheumatoid Arthritis
Kacy Arnold, RN MBAStudy DirectorZimmer Biomet
7 Previous Clinical Trials
744 Total Patients Enrolled
1 Trials studying Rheumatoid Arthritis
135 Patients Enrolled for Rheumatoid Arthritis
Erin Osborn, MBAStudy DirectorZimmer Biomet
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am older than 18 years.I am not a prisoner, mentally competent, understand the study, and do not abuse substances.I have severe ankle issues or nerve/blood vessel diseases affecting my leg.I have an infection that could impact a joint replacement.My bones have stopped growing.I am eligible for an ankle replacement due to arthritis or injury.I am ready and can follow through with the needed therapy after surgery.My bones are too weak or damaged to support surgical implants.I have had an infection in my joint before.
Research Study Groups:
This trial has the following groups:- Group 1: Zimmer TM Total Ankle System
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.